Search results for "3. Good health"

showing 10 items of 4761 documents

Defying Stereotypes with Nanodiamonds: Stable Primary Diamondoid Phosphines

2016

International audience; Direct unequal C-H bond difunctionalization of phosphorylated diamantane was achieved in high yield from the corresponding phosphonates. Reduction of the functionalized phosphonates provides access to novel primary and secondary alkyl/aryl diamantane phosphines. The prepared primary diamantyl phosphines are quite air stable compared to their adamantyl and especially alkyl or aryl analogues. This finding is corroborated by comparing the singly occupied molecular orbital energy levels of the corresponding phosphine radical cations obtained by density functional theory computations.

room-temperaturemolecular tripoddeactivated aryl chlorideshomogeneous catalysts010402 general chemistryDiamondoidselective preparationchemistry01 natural sciencesMedicinal chemistryChemical reaction[ CHIM ] Chemical Scienceschemistry.chemical_compoundOrganic chemistry[CHIM]Chemical SciencesarylationAlkylNanodiamonds ; Diamondoid Phosphines ; diamantane ; adamantane ; adamantylphosphinechemistry.chemical_classification010405 organic chemistryChemistryligandsArylOrganic Chemistrypalladiumphosphorylated adamantanes3. Good health0104 chemical sciencesChemical bondDensity functional theoryDiamantanePhosphine
researchProduct

3,4,5-Trimethoxy-4'-methylbiphenyl

2013

In the title compound, C16H18O3, the dihedral angle between the benzene rings is 33.4 (2)°. In the crystal, mol­ecules are packed in a zigzag arrangement along the b-axis and are inter­connected via weak C—H⋯O hydrogen bonds, and C—H⋯π inter­actions involving the meth­oxy groups and the benzene rings of neighbouring molecules.

röntgendiffraktiocrystal structure010405 organic chemistryHydrogen bonddendrimeeri prekursoriGeneral ChemistrykiderakenneDihedral angle010402 general chemistryCondensed Matter Physics01 natural sciencesOrganic Papers3. Good health0104 chemical sciencesX-ray diffractionCrystalchemistry.chemical_compoundCrystallographychemistryZigzagdendrimer precursorMoleculeGeneral Materials ScienceBenzeneta116Acta Crystallographica Section E-Structure Reports Online
researchProduct

3,5-Dimethoxy-4'-methylbiphenyl

2013

The title compound, C15H16O2, crystallizes with three independent mol­ecules in the asymmetric unit. The intra­molecular torsion angle between the aromatic rings of each mol­ecule are −36.4 (3), 41.3 (3) and −37.8 (3)°. In the crystal, the complicated packing of the mol­ecules forms wave-like layers along the b and c axes. The mol­ecules are connected via extensive meth­oxy–phenyl C—H…π inter­actions. A weak C—H…O hydrogen-bonding network also exists between meth­oxy O atoms and aromatic or meth­oxy H atoms.

röntgendiffraktiocrystal structuredendrimeeri prekursori010405 organic chemistryChemistryX-ray DiffractionAromaticitykiderakenneGeneral ChemistryDihedral angle010402 general chemistryCondensed Matter PhysicsBioinformaticsOrganic Papers01 natural sciences0104 chemical sciences3. Good healthCrystalCrystallographydendrimer precursorGeneral Materials Scienceta116
researchProduct

3,4-Dimethoxy-4'-methylbiphenyl

2013

In the title compound, C15H16O2, the dihedral angle between the planes of the aromatic rings is 30.5 (2). In the crystal, molecules are linked via C—HO hydrogen bonds and C— H interactions, forming a two-dimensional network lying parallel to (100). peerReviewed

röntgendiffraktiocrystal structuredendrimeeri prekursori010405 organic chemistryHydrogen bondChemistryAromaticitykiderakenneGeneral ChemistryDihedral angle010402 general chemistryCondensed Matter Physics01 natural sciencesOrganic PapersX-ray diffraction0104 chemical sciences3. Good healthCrystalCrystallographydendrimer precursorGeneral Materials Scienceta116Acta Crystallographica Section E-Structure Reports Online
researchProduct

Methyl 3',5'-dimethoxybiphenyl-4-carboxylate

2013

In the title compound, C16H16O4, the dihedral angle between the benzene rings is 28.9 (2)°. In the crystal, mol­ecules are packed in layers parallel to the b axis in which they are connected via weak inter­molecular C-H...O contacts. Face-to-face π-π inter­actions also exist between the benzene rings of adjacent mol­ecules, with centroid-centroid and plane-to-plane shift distances of 3.8597 (14) and 1.843 (2) Å, respectively.

röntgendiffraktiocrystal structuredendrimeeri prekursorikiderakenneDihedral angle010402 general chemistryBioinformatics01 natural sciencesOrganic PapersCrystalchemistry.chemical_compoundGeneral Materials ScienceBenzeneta116Biphenyl010405 organic chemistryHydrogen bondGeneral ChemistryMeth-Condensed Matter PhysicsX-ray diffraction0104 chemical sciences3. Good healthCrystallographychemistrydendrimer precursorLayer (electronics)
researchProduct

Methyl 3',4',5'-trimethoxybiphenyl-4-carboxylate

2013

In the title compound, C17H18O5, the dihedral angle between the benzene rings is 31.23 (16)°. In the crystal, the mol­ecules are packed in an anti­parallel fashion in layers along the a axis. In each layer, very weak C-H...O hydrogen bonds occur between the meth­oxy and methyl ester groups. Weak C-H...[pi] inter­actions between the 4'- and 5'-meth­oxy groups and neighbouring benzene rings [meth­oxy-C-ring centroid distances = 4.075 and 3.486 Å, respectively] connect the layers.

röntgendiffraktiocrystal structuredendrimeeriprekursorikiderakenneDihedral angle010402 general chemistry010403 inorganic & nuclear chemistryAntiparallel (biochemistry)01 natural sciencesOrganic PapersCrystalchemistry.chemical_compoundMoleculeGeneral Materials ScienceCarboxylateBenzeneta116ChemistryHydrogen bondGeneral ChemistryCondensed Matter Physics3. Good health0104 chemical sciencesX-ray diffractionCrystallographydendrimer precursorSingle crystal
researchProduct

Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study

2016

Purpose The PRAME tumour antigen is expressed in several tumour types but in few normal adult tissues. A dose-escalation phase I/II study (NCT01149343) assessed the safety, immunogenicity and clinical activity of the PRAME immunotherapeutic (recombinant PRAME protein (recPRAME) with the AS15 immunostimulant) in patients with advanced melanoma. Here, we report the phase I dose-escalation study segment. Patients and methods Patients with stage IV PRAME-positive melanoma were enrolled to 3 consecutive cohorts to receive up to 24 intramuscular injections of the PRAME immunotherapeutic. The RecPRAME dose was 20, 100 or 500 µg in cohorts 1, 2 and 3, respectively, with a fixed dose of AS15. Advers…

safetyCancer Researchmedicine.drug_classmedicine.medical_treatmentMedizinPhases of clinical research[SDV.CAN]Life Sciences [q-bio]/CancerimmunogenicityImmunostimulant03 medical and health sciences0302 clinical medicine[SDV.CAN] Life Sciences [q-bio]/CancerCancer immunotherapymedicine1506030304 developmental biologyOriginal ResearchPRAME antigen0303 health sciencesPRAMEcancer immunotherapybusiness.industryMelanomaImmunogenicityCancermedicine.disease3. Good healthOncology030220 oncology & carcinogenesisImmunologyChillsmedicine.symptombusinessmetastatic melanoma
researchProduct

Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial

2020

Funding: Transgène; International audience; Treatment of chronic hepatitis B (CHB) typically requires life-long administration of drugs. Cohort and pre-clinical studies have established the link between a functional T-cell-mounted immunity and resolution of infection. TG1050 is an adenovirus 5-based vaccine that expresses HBV polymerase and domains of core and surface antigen and has shown immunogenicity and antiviral effects in mice. We performed a phase 1 clinical trial to assess safety and explore immunogenicity and early efficacy of TG1050 in CHB patients. This randomized, double blind, placebo-controlled study included two sequential phases: one single dose cohort (SD, n = 12) and one …

safetyHBsAg030231 tropical medicineImmunologyPlacebo-controlled studyPhases of clinical researchSciences du Vivant [q-bio]/Médecine humaine et pathologieimmunogenicityPlaceboAntiviral AgentsAdenoviridae03 medical and health sciencesMice0302 clinical medicineHepatitis B ChronicImmunogenicity VaccinevaccineImmunology and AllergyMedicineAnimalsHumans030212 general & internal medicineAdverse effectPharmacologyVaccinesHepatitis B Surface Antigens[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologybusiness.industryELISPOTImmunogenicitychronicityimmuno-therapyHepatitis Bmedicine.diseaseHepatitis B3. Good healthImmunologybusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyResearch Paper
researchProduct

Common variants at VRK2 and TCF4 conferring risk of schizophrenia

2011

To access publisher full text version of this article. Please click on the hyperlink in Additional Links field. Common sequence variants have recently joined rare structural polymorphisms as genetic factors with strong evidence for association with schizophrenia. Here we extend our previous genome-wide association study and meta-analysis (totalling 7 946 cases and 19 036 controls) by examining an expanded set of variants using an enlarged follow-up sample (up to 10 260 cases and 23 500 controls). In addition to previously reported alleles in the major histocompatibility complex region, near neurogranin (NRGN) and in an intron of transcription factor 4 (TCF4), we find two novel variants show…

schizophrenia; sequence variants; TCF4Genome-wide association studyTranscription Factor 40302 clinical medicineVRK2 protein humanPolymorphism (computer science)Genotypegenetics [Schizophrenia]NeurograninGenetics (clinical)Schizophrenia; Genotype; Risk; Alleles; Polymorphism Single Nucleotide; Transcription Factors; Humans; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Genetic Predisposition to Disease; Protein-Serine-Threonine Kinases; Genome-Wide Association StudyGenetics0303 health sciencesBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsAssociation Studies ArticlesSingle NucleotideGeneral MedicineTCF4genetics [Transcription Factors]Protein-Serine-Threonine Kinases3. Good healthJRiskGenotypeProtein Serine-Threonine KinasesBiologyPolymorphism Single Nucleotidegenetics [Protein-Serine-Threonine Kinases]Molecular epidemiology [NCEBP 1]03 medical and health sciencesddc:570GeneticsHumansGenetic Predisposition to DiseasePolymorphismAllelegenetics [Basic Helix-Loop-Helix Leucine Zipper Transcription Factors]Settore MED/25 - PsichiatriaMolecular BiologyAllelesTCF4Molecular epidemiology Aetiology screening and detection [NCEBP 1]030304 developmental biologysequence variantsIntronOdds ratioMolecular biologySchizophreniaTCF4 protein human030217 neurology & neurosurgeryGenome-Wide Association StudyTranscription Factors
researchProduct

Consensus nomenclature for CD8(+) T cell phenotypes in cancer

2015

International audience; Whereas preclinical investigations and clinical studies have established that CD8+ T cells can profoundly affect cancer progression, the underlying mechanisms are still elusive. Challenging the prevalent view that the beneficial effect of CD8+ T cells in cancer is solely attributable to their cytotoxic activity, several reports have indicated that the ability of CD8+ T cells to promote tumor regression is dependent on their cytokine secretion profile and their ability to self-renew. Evidence has also shown that the tumor microenvironment can disarm CD8+ T cell immunity, leading to the emergence of dysfunctional CD8+ T cells. The existence of different types of CD8+ T…

senescenceT cellOncology and CarcinogenesisImmunology[SDV.CAN]Life Sciences [q-bio]/CancerBiologyCD8+ T cellsIFN gammaanergy03 medical and health sciencesstemness0302 clinical medicineImmune system[SDV.CAN] Life Sciences [q-bio]/Cancerexhaustionmedicine2.1 Biological and endogenous factorsImmunology and AllergyCytotoxic T cellAetiologyPoint of ViewCancer030304 developmental biologyCD8+ T cells; IFNγ; anergy; anticancer immunity; cytotoxicity; effector; exhaustion; senescence; stemness0303 health sciencesTumor microenvironmentCD8(+) T cellsCancermedicine.diseasePhenotype3. Good healthanticancer immunitymedicine.anatomical_structureeffectorOncologyImmunologycytotoxicityCytokine secretionCD8030215 immunologyIFNγ
researchProduct